Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson’s disease and essential tremor

Neurological Sciences

Volumn 36, Issue 8, 2015, Pages 1403-1410

  Štenc Bradvica, Ivanka ^a   Mihaljević, Ivan ^a   Butković Soldo, Silva ^a   Kadojić, Dragutin ^a   Titlić, Marina ^b   Bradvica, Mario ^a   Kralik, Kristina ^c  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

^c JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

DaTSCAN; Olfactory dysfunction; Parkinsonism; Transcranial sonography

Indexed keywords

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DOPAMIN TRANSPORTER SCAN IMAGING; DOPPLER ECHOGRAPHY; ESSENTIAL TREMOR; FEMALE; HUMAN; IMAGING AND DISPLAY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POCKET SMELL TEST; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; AGED; ANIMAL; COMPLICATION; MIDDLE AGED; NONPARAMETRIC TEST; OLFACTION DISORDERS; OSMERIFORMES; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DIAGNOSIS, DIFFERENTIAL; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; OLFACTION DISORDERS; OSMERIFORMES; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84938210784     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2152-y     Document Type: Article

References (40)

1. Deuschl G, Elble R (2009) Essential tremor–neurodegenerative or nondegenerative disease towards a working definition of ET. Mov Disord 24(14):2033–2041. doi:10.1002/mds.22755
2. Lacerte A, Chouinard S, Jodoin N, Bernard G, Rouleau GA, Panisset M (2014) Increased prevalence of non-motor symptoms in essential tremor. Tremor Other Hyperkinet Mov (N Y) 4:162. doi:10.7916/D82V2D91
3. Tan EK, Lee SS, Fook-Chong S, Lum SY (2008) Evidence of increased odds of essential tremor in Parkinson’s disease. Mov Disord 23(7):993–997. doi:10.1002/mds.22005
4. Shahed J, Jankovic J (2007) Exploring the relationship between essential tremor and Parkinson’s disease. Parkinsonism Relat Disord 13(2):67–76. doi:10.1016/j.parkreldis.2006.05.033
5. Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M (2013) EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson’s disease. Eur J Neurol 20(1):16–34. doi:10.1111/ene.12022
6. Bajaj N, Hauser RA, Grachev ID (2013) Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. J Neurol Neurosurg Psychiatry 84(11):1288–1295. doi:10.1136/jnnp-2012-304436
7. Isaias IU, Canesi M, Benti R, Gerundini P, Cilia R, Pezzoli G, Antonini A (2008) Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl Med Commun 29(4):349–353. doi:10.1097/MNM.0b013e3282f4d307
8. Stenc Bradvica I, Bradvica M, Matic S, Reisz-Majic P (2014) Visual dysfunction in patients with Parkinson’s disease and essential tremor. Neurol Sci. doi:10.1007/s10072-014-1930-2
9. Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson’s disease: a prospective blinded study. Lancet Neurol 7(5):417–424. doi:10.1016/S1474-4422(08)70067-X
10. Walter U (2010) Transcranial sonography in brain disorders with trace metal accumulation. Int Rev Neurobiol 90:166–178. doi:10.1016/S0074-7742(10)90012-3
11. Budisic M, Trkanjec Z, Lovrencic-Huzjan A, Supanc V, Vukovic V, Demarin V (2009) Transcranial sonography (TCS) in evaluation of patients with essential tremor. Acta Med Croatica 63(Suppl 3):51–54
12. Vlaar AM, de Nijs T, van Kroonenburgh MJ, Mess WH, Winogrodzka A, Tromp SC, Weber WE (2008) The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol 8:42. doi:10.1186/1471-2377-8-42
13. Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H (2004) Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19(10):1196–1202. doi:10.1002/mds.20141
14. Duff K, McCaffrey RJ, Solomon GS (2002) The Pocket Smell Test: successfully discriminating probable Alzheimer’s dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci 14(2):197–201
15. Shah M, Muhammed N, Findley LJ, Hawkes CH (2008) Olfactory tests in the diagnosis of essential tremor. Parkinsonism Relat Disord 14(7):563–568. doi:10.1016/j.parkreldis.2007.12.006
16. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography. Neurology 45(1):182–184
17. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D (2003) Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes. Neurology 60(1):74–77
18. Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7(11):1044–1055. doi:10.1016/S1474-4422(08)70239-4
19. Vlaar AM, van Kroonenburgh MJ, Kessels AG, Weber WE (2007) Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol 7:27. doi:10.1186/1471-2377-7-27
20. Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, Schaid DJ, Maraganore DM (2007) Increased risk of essential tremor in first-degree relatives of patients with Parkinson’s disease. Mov Disord 22(11):1607–1614. doi:10.1002/mds.21584
21. Chitsaz A, Mehrbod N, Saadatnia M, Fereidan-Esfahani M, Akbari M, Abtahi SH (2013) Transcranial sonography on Parkinson’s disease and essential tremor. J Res Med Sci 18(Suppl 1):S28–S31
22. Ressner P, Skoloudik D, Hlustik P, Kanovsky P (2007) Hyperechogenicity of the substantia nigra in Parkinson’s disease. J Neuroimaging 17(2):164–167. doi:10.1111/j.1552-6569.2007.00114.x
23. Stockner H, Sojer M, K KS, Mueller J, Wenning GK, Schmidauer C, Poewe W (2007) Midbrain sonography in patients with essential tremor. Mov Disord 22(3):414–417. doi:10.1002/mds.21344
24. Doepp F, Plotkin M, Siegel L, Kivi A, Gruber D, Lobsien E, Kupsch A, Schreiber SJ (2008) Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson’s disease and essential tremor. Mov Disord 23(3):405–410. doi:10.1002/mds.21861
25. Hernandez Vara J, Rubiera del Fueyo M, Lorenzo Bosquet C, Castell Conesa J, Molina Cateriano CA, Rodriguez FM (2008) Usefulness of transcranial sonography in Parkinson’s disease. A comparative study using 123I-FP-CIT SPECT. Med Clin (Barc) 131(8):285–289
26. Huisman E, Uylings HB, Hoogland PV (2004) A 100 % increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov Disord 19(6):687–692. doi:10.1002/mds.10713
27. McKinnon J, Evidente V, Driver-Dunckley E, Premkumar A, Hentz J, Shill H, Sabbagh M, Caviness J, Connor D, Adler C (2010) Olfaction in the elderly: a cross-sectional analysis comparing Parkinson’s disease with controls and other disorders. Int J Neurosci 120(1):36–39. doi:10.3109/00207450903428954
28. Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 22(6):839–842. doi:10.1002/mds.21413
29. Braak H, Rub U, Braak E (2000) Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems. Nervenarzt 71(6):459–469
30. Doty RL (1994) Studies of olfactory dysfunction in major neurological disorders. Adv Biosci 93:593–602
31. Silveira-Moriyama L, Carvalho Mde J, Katzenschlager R, Petrie A, Ranvaud R, Barbosa ER, Lees AJ (2008) The use of smell identification tests in the diagnosis of Parkinson’s disease in Brazil. Mov Disord 23(16):2328–2334. doi:10.1002/mds.22241
32. Haehner A, Hummel T, Reichmann H (2009) Olfactory dysfunction as a diagnostic marker for Parkinson’s disease. Expert Rev Neurother 9(12):1773–1779. doi:10.1586/ern.09.115
33. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC (1992) Olfactory function in essential tremor. Neurology 42(8):1631–1632
34. Quagliato LB, Viana MA, Quagliato EM, Simis S (2009) Olfaction and essential tremor. Arq Neuropsiquiatr 67(1):21–24 (S0004-282X2009000100006 [pii])
35. Louis ED, Bromley SM, Jurewicz EC, Watner D (2002) Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 59(10):1631–1633
36. Vennemann MM, Hummel T, Berger K (2008) The association between smoking and smell and taste impairment in the general population. J Neurol 255(8):1121–1126. doi:10.1007/s00415-008-0807-9
37. Djaldetti R, Nageris BI, Lorberboym M, Treves TA, Melamed E, Yaniv E (2008) [(123)I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. J Neural Transm 115(3):469–472. doi:10.1007/s00702-007-0851-0
38. Chen W, Tan YY, Hu YY, Zhan WW, Wu L, Lou Y, Wang X, Zhou Y, Huang P, Gao Y, Xiao Q, Chen SD (2012) Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson’s disease: a pilot study from China. Transl Neurodegener 1(1):25. doi:10.1186/2047-9158-1-25
39. Busse K, Heilmann R, Kleinschmidt S, Abu-Mugheisib M, Hoppner J, Wunderlich C, Gemende I, Kaulitz L, Wolters A, Benecke R, Walter U (2012) Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(4):441–447. doi:10.1136/jnnp-2011-301719
40. Poewe W, Mahlknecht P (2012) Combined assessment of midbrain hyperechogenicity, hyposmia and motor asymmetry improves diagnostic accuracy in early Parkinson’s disease. Expert Rev Neurother 12(8):911–914. doi:10.1586/ern.12.75